Author:
Cannon Grant W.,McCall Shawna,Cole Barry C.,Radov Lesley A.,Ward John R.,Griffiths Marie M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference28 articles.
1. M. Cremer,Type II collagen-induced arthritis in rats. InHandbook of Animal Models for the Rheumatic Disease Volume 1. (Eds. R. A. Greenwald and H. S. Diamond) pp. 17–27, CRC Press, Boca Raton, FL 1988.
2. M. M. Griffiths, E. J. Eichwald, J. H. Martin, C. B. Smith and C. W. DeWitt,Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arth. Rheum.24, 781–789 (1981).
3. M. M. Griffiths and C. W. DeWitt,Immunogenetic control of experimental collagen-induced arthritis in rats. II. ECIA susceptibility and immune response to type II collagen (calf) are linked to RT1. J. Immunogen.8, 463–470 (1981).
4. C. Arita, N. Kaibara, T. Hotokebuchi, K. Takagishi and K. Arai,Effect of cyclophosphamide and its analogs on collagen arthritis in rats. Clin. Immunol. Immunopathol.43, 354–361 (1987).
5. K. Komoriya, I. Nagata, K. Kunisawa, T. Takeshita, and N. Tatsuyuki,Anti-arthritic and immunoregulatory effects of TI-31 on collagen-induced arthritis. Jap. J. Pharmacol.45, 389–396 (1987).
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献